Lupin Limited — Updates, 17-07-2025: Press Release

Lupin's subsidiary, Lupin Manufacturing Solutions (LMS), secured Good Manufacturing Practice (GMP) certification from Australia’s Therapeutic Goods Administration (TGA) for its Dabhasa API facility. This is a significant operational development, strengthening LMS's pharmaceutical CDMO services and API supply capabilities in Australia. The certification underscores high manufacturing standards and compliance, supporting Lupin's global expansion in the contract development and manufacturing sector. This move enhances the company's competitive position and market access for its products.